SPRINGVILLE, TN--GroGenesis, Inc. (OTCQB: GROG) ("GroGenesis" or the "Company"), rights holders, developers and manufacturers of innovative agricultural enhancement products, is pleased to advise that as part of its ongoing business development process it has resolved to refine the market segmentation and commercial roll out potential for its first two products: AgraBurst and AgraBlast.
Based on internal studies, Company management has determined to realize increased market awareness in the nascent biostimulant sector, a recent and growing industry classification that shows great promise as an agricultural nexus of new technological advancements and commercial adoption. Within a few short years since its inception, the European Biostimulants Industry Council (EBIC, founded June, 2011) today indicates that more than 3 million hectares are treated with repeated biostimulant applications in Europe every year. MarketsandMarkets of Dallas, Texas, reports that the value of the worldwide biostimulants market is projected to increase to $2.5 billion, at a CAGR of 12.5%, by 2019. Market Publishers of Birmingham, UK, reports the North American biostimulants market is estimated to grow at a CAGR of 14.1% from 2014 to 2019. As a result, GroGenesis intends to focus on initiating agreements with potential biostimulant distributors that are positioned to immediately target European and North American partners looking to increase crop yields through the development of regional treatment programs featuring AgraBurst.
In related news, market research institute Ceresana Research of Konstanz, Germany forecasts 2019 revenues will be greater than US $52 billion for the global market of crop protection products. The most important sales region for crop protection products in 2011 was Asia-Pacific, with a 33% share of worldwide consumption, followed by South America, Western Europe, and North America. Based on this data combined with positive results from recent field trials in Central America, GroGenesis intends to focus on signing distributors that can immediately target South America with AgraBlast, a proven non-toxic solution for the treatment of economically important crops affected by significant pathogenic fungal diseases such as Coffee Roya (aka "Coffee Rust") and Black Sigatoka on Bananas.
Company CEO and President, Joe Fewer notes, "We feel the biostimulant market has come a long way in a very short timeframe, and we look forward to working closely with some of the new and innovative technologies just coming to the forefront of the agricultural industry as a whole. Crop protection and remediation products integrated with novel health enhancement programs are looking to be the future of agriculture in an increasingly stressed global environment. The work we and others like us are doing today should have an immense impact on feeding future generations and we are fully aware that this represents a shifting economic and societal reality that we believe could present great future benefits for our company and shareholders alike."
Additional details of the Company's business, finances, appointments and agreements can be found in its ongoing filings which forms part of the Company's continuous public disclosure as a reporting issuer with the Securities and Exchange Commission ("SEC") available atwww.sec.gov.
About GroGenesis, Inc. (OTCQB: GROG)
GroGenesis aims to become a leading producer of natural plant growth health technologies. The Company's 'AgraBurst' is a biostimulant blended from processed extracts of natural plant materials that directly improves the positive effects of commercial fertilizers and available nutrients. GroGenesis also offers "AgraBlast," as a companion crop protection product designed as an eco-friendly, non-toxic alternative to synthetic fungicides. When used in combination (as directed), the Company offers an innovative solution for the control of plant pathogenic fungi and for plant remediation and stimulation of yields. Find out more at www.grogenesis.com.
Cautionary Language Concerning Forward-Looking Statements:
Information set forth in this press release contains forward-looking statements that are subject to risks and uncertainties, and actual results might differ materially. A discussion of factors that may affect future results is contained in the GroGenesis filings with the Securities and Exchange Commission available at: www.sec.gov. GroGenesis disclaims any obligation to update and revise statements contained in this news release based on new information or otherwise.